Detalles de la búsqueda
1.
Significance of ramucirumab following atezolizumab plus bevacizumab therapy for hepatocellular carcinoma using real-world data.
Hepatol Res
; 53(2): 116-126, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36316794
2.
The beneficial impact of metabolic dysfunction-associated fatty liver disease on lenvatinib treatment in patients with non-viral hepatocellular carcinoma.
Hepatol Res
; 53(2): 104-115, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36149726
3.
Telephone follow-up contributes to improving adherence and treatment duration in patients with hepatocellular carcinoma treated with lenvatinib.
J Gastroenterol Hepatol
; 38(7): 1140-1147, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36880677
4.
Efficacy of Lenvatinib Combined with Transcatheter Intra-Arterial Therapies for Patients with Advanced-Stage of Hepatocellular Carcinoma: A Propensity Score Matching.
Int J Mol Sci
; 24(18)2023 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37762018
5.
[A case of difficult treatment of infected pseudoaneurysm of the femoral artery during hepatic arterial infusion chemotherapy for hepatocellular carcinoma].
Nihon Shokakibyo Gakkai Zasshi
; 120(3): 263-268, 2023.
Artículo
en Japonés
| MEDLINE | ID: mdl-36908145
6.
Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival.
Oncology
; 99(12): 756-765, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34518483
7.
Lenvatinib versus Sorafenib as first-line treatment in hepatocellular carcinoma: A multi-institutional matched case-control study.
Hepatol Res
; 51(12): 1229-1241, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34591334
8.
Increased Arterio-Portal Shunt Formation after Drug-Eluting Beads TACE for Hepatocellular Carcinoma.
Oncology
; 98(8): 558-565, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32422633
9.
[A case of hemobilia due to the rupture of pancreaticoduodenal artery aneurysm with choledocholithiasis].
Nihon Shokakibyo Gakkai Zasshi
; 117(1): 92-98, 2020.
Artículo
en Japonés
| MEDLINE | ID: mdl-31941863
10.
Epirubicin is More Effective than Miriplatin in Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.
Oncology
; 96(2): 79-86, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30293080
11.
Dose and Location of Irradiation Determine Survival for Patients with Hepatocellular Carcinoma with Macrovascular Invasion in External Beam Radiation Therapy.
Oncology
; 96(4): 192-199, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30650415
12.
Prognostic impact of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation in patients with unresectable hepatocellular carcinoma: Comparison with TACE alone using decision-tree analysis after propensity score matching.
Hepatol Res
; 49(8): 919-928, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30969006
13.
Effects of in-hospital exercise on sarcopenia in hepatoma patients who underwent transcatheter arterial chemoembolization.
J Gastroenterol Hepatol
; 34(3): 580-588, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30402913
14.
Effects of in-hospital exercise on liver function, physical ability, and muscle mass during treatment of hepatoma in patients with chronic liver disease.
Hepatol Res
; 47(3): E22-E34, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27062043
15.
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity.
Clin Mol Hepatol
; 29(3): 593-604, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36775834
16.
The impact of curative conversion therapy aimed at a cancer-free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Cancer Med
; 12(11): 12325-12335, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37062077
17.
Tumor-derived insulin-like growth factor-binding protein-1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors.
Cancer Commun (Lond)
; 43(4): 415-434, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36825684
18.
Preoperative Chemotherapy Followed by Hepatectomy for Potentially Resectable UICC7 Stage IIIA, IIIB Hepatocellular Carcinoma; A Phase II Clinical Trial.
Kurume Med J
; 68(3.4): 239-245, 2023 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37518005
19.
Evaluating the therapeutic effect of lenvatinib against advanced hepatocellular carcinoma by measuring blood flow changes using contrast-enhanced ultrasound.
Cancer Rep (Hoboken)
; 5(2): e1471, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34105904
20.
Association between contrast enhancement on contrast-enhanced CT and lenvatinib effectiveness in hepatocellular carcinoma.
Mol Clin Oncol
; 16(1): 8, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34881028